Status Page Transition Complete
As of April 26, 2026, all applicable products have successfully transitioned to a single, consolidated status page to improve service visibility and consistency.
All products are now available at https://status.optum.com, except Pharmacy products, which will transition at a later date. We appreciate your patience as we continue to enhance our status and communication experience.
Scheduled
Optum Insight has completed claims testing in collaboration with the Provider Outreach & Education (POE) team to validate payment accuracy and claim reopening outcomes with the new dispense fee modifier. Based on this review, please disregard our former instruction for non-Recovery clients to take related denials to re-openings. We are actively addressing inhalation dispense fee denials for both Recovery & non-Recovery clients which occurred before inhalation claims were placed on hold Feb. 20, 2026. No action is required from providers currently.
System enhancements resulting from this collaborative testing are scheduled for completion by mid-April. At that time, claims that were previously on hold will be released for processing. We appreciate your continued partnership.
System enhancements resulting from this collaborative testing are scheduled for completion by mid-April. At that time, claims that were previously on hold will be released for processing. We appreciate your continued partnership.
This scheduled maintenance affects: MedRx.